| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Departments of Neuropharmacology *
and
Molecular Biology,
The Scripps Research
Institute, and the Department of Pathology,
University of California at San Diego, La Jolla, California
To examine the role of tumor necrosis factor (TNF)-
in the
pathogenesis of degenerative disorders of the central nervous system
(CNS), transgenic mice were developed in which expression of
murine TNF-
was targeted to astrocytes using a glial fibrillary
acidic protein (GFAP)-TNF-
fusion gene. In two independent
GFAP-TNF
transgenic lines (termed GT-8 or GT-2) adult (>4 months of
age) animals developed a progressive ataxia (GT-8) or total paralysis
affecting the lower body (GT-2). Symptomatic mice had prominent
meningoencephalitis (GT-8) or encephalomyelitis (GT-2) in which large
numbers of B cells and CD4+ and CD8+ T cells
accumulated at predominantly perivascular sites. The majority of these
lymphocytes displayed a memory cell phenotype
(CD44high, CD62Llow,
CD25-) and expressed an early activation marker (CD69).
Parenchymal lesions contained mostly CD45+ high,
MHC class II+, and Mac-1+ cells of the
macrophage microglial lineage with lower numbers of neutrophils and few
CD4+ and CD8+ T cells. Cerebral expression of
the cellular adhesion molecules ICAM-1, VCAM-1, and
MAdCAM as well as a number of
- and ß-chemokines was induced or
up-regulated and preceded the development of inflammation,
suggesting an important signaling role for these molecules in the CNS
leukocyte migration. Degenerative changes in the CNS of the GFAP-TNF
mice paralleled the development of the inflammatory lesions and
included primary and secondary demyelination and neurodegeneration.
Disease exacerbation with more extensive inflammatory lesions that
contained activated cells of the macrophage/microglial lineage occurred
in GFAP-TNF
mice with severe combined immune deficiency.
Thus, persistent astrocyte expression of murine TNF-
in the
CNS induces a late-onset chronic inflammatory encephalopathy in which
macrophage/microglial cells but not lymphocytes play a central role in
mediating injury.
This article has been cited by other articles:
![]() |
M. L. Kim, B. Zhang, I. P. Mills, M. E. Milla, K. R. Brunden, and V. M.-Y. Lee Effects of TNF{alpha}-Converting Enzyme Inhibition on Amyloid {beta} Production and APP Processing In Vitro and In Vivo J. Neurosci., November 12, 2008; 28(46): 12052 - 12061. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Shaftel, T. J. Carlson, J. A. Olschowka, S. Kyrkanides, S. B. Matousek, and M. K. O'Banion Chronic Interleukin-1{beta} Expression in Mouse Brain Leads to Leukocyte Infiltration and Neutrophil-Independent Blood Brain Barrier Permeability without Overt Neurodegeneration J. Neurosci., August 29, 2007; 27(35): 9301 - 9309. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Antony, K. K. Ellestad, R. Hammond, K. Imaizumi, F. Mallet, K. G. Warren, and C. Power The Human Endogenous Retrovirus Envelope Glycoprotein, Syncytin-1, Regulates Neuroinflammation and Its Receptor Expression in Multiple Sclerosis: A Role for Endoplasmic Reticulum Chaperones in Astrocytes J. Immunol., July 15, 2007; 179(2): 1210 - 1224. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Peterson, S. Hughes, D. E. Dimcheff, K. Wehrly, and B. Chesebro Separate Sequences in a Murine Retroviral Envelope Protein Mediate Neuropathogenesis by Complementary Mechanisms with Differing Requirements for Tumor Necrosis Factor Alpha J. Virol., December 1, 2004; 78(23): 13104 - 13112. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Boos, I. L. Campbell, R. Ames, R. A. Wetsel, and S. R. Barnum Deletion of the Complement Anaphylatoxin C3a Receptor Attenuates, Whereas Ectopic Expression of C3a in the Brain Exacerbates, Experimental Autoimmune Encephalomyelitis J. Immunol., October 1, 2004; 173(7): 4708 - 4714. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Poluektova, S. Gorantla, J. Faraci, K. Birusingh, H. Dou, and H. E. Gendelman Neuroregulatory Events Follow Adaptive Immune-Mediated Elimination of HIV-1-Infected Macrophages: Studies in a Murine Model of Viral Encephalitis J. Immunol., June 15, 2004; 172(12): 7610 - 7617. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Boztug, M. J. Carson, N. Pham-Mitchell, V. C. Asensio, J. DeMartino, and I. L. Campbell Leukocyte Infiltration, But Not Neurodegeneration, in the CNS of Transgenic Mice with Astrocyte Production of the CXC Chemokine Ligand 10 J. Immunol., August 1, 2002; 169(3): 1505 - 1515. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Haring, L. L. Pewe, and S. Perlman Bystander CD8 T Cell-Mediated Demyelination After Viral Infection of the Central Nervous System J. Immunol., August 1, 2002; 169(3): 1550 - 1555. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Peterson, S. J. Robertson, J. L. Portis, and B. Chesebro Differences in Cytokine and Chemokine Responses during Neurological Disease Induced by Polytropic Murine Retroviruses Map to Separate Regions of the Viral Envelope Gene J. Virol., March 15, 2001; 75(6): 2848 - 2856. [Abstract] [Full Text] |
||||
![]() |
K. D. Bornemann, K.-H. Wiederhold, C. Pauli, F. Ermini, M. Stalder, L. Schnell, B. Sommer, M. Jucker, and M. Staufenbiel A{beta}-Induced Inflammatory Processes in Microglia Cells of APP23 Transgenic Mice Am. J. Pathol., January 1, 2001; 158(1): 63 - 73. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Jensen, I. V. Hegelund, N. D. Lomholt, B. Finsen, and T. Owens IFNgamma Enhances Microglial Reactions to Hippocampal Axonal Degeneration J. Neurosci., May 15, 2000; 20(10): 3612 - 3621. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Davoust, S. Nataf, R. Reiman, M. V. Holers, I. L. Campbell, and S. R. Barnum Central Nervous System-Targeted Expression of the Complement Inhibitor sCrry Prevents Experimental Allergic Encephalomyelitis J. Immunol., December 15, 1999; 163(12): 6551 - 6556. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Bergmann, J. D. Altman, D. Hinton, and S. A. Stohlman Inverted Immunodominance and Impaired Cytolytic Function of CD8+ T Cells During Viral Persistence in the Central Nervous System J. Immunol., September 15, 1999; 163(6): 3379 - 3387. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |